Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 12 results for "herceptin"

Mylan inks settlement pact with Genentech & Roche on cancer dr...

Trastuzumab (Herceptin) is one of the 6 biologic products co-developed by Mylan & Biocon BS B2B Bureau | Pittsburgh, USA March 14, 2017 Last Updated at 16:28 IST Mylan NV has agreed to the terms of a global settlement with Genentech Inc and F. Hoffmann-La ... Business Standard, 2 months ago

30 images for herceptin

Med India, 2 months ago, 4 months ago
Nasdaq, 4 months ago
Nasdaq, 4 months ago
Nasdaq, 4 months ago
FiercePharma, 5 months ago
Cancer Therapy Advisor, 5 months ago
Ecancer Medicalscience, 5 months ago, 5 months ago
Libya News Today, 5 months ago

Mylan deal clears path for biosimilar copy of Roche's Herceptin

LONDON (Reuters) - Generic drugmaker Mylan said on Monday it had reached a settlement with Roche providing "a clear pathway" for the launch of its biosimilar version of the Swiss company's top-selling breast cancer drug Herceptin in major markets.
 Business Standard2 months ago

Roche says drug combo cuts breast cancer deaths in key trial

ZURICH (Reuters) - Combining Roche's Perjeta and Herceptin drugs with chemotherapy reduced recurrence of aggressive breast cancer or death compared to Herceptin and chemo, the Swiss drugmaker said on Thursday.
 Business Standard2 months ago Roche trial finds new drug cocktail cuts breast cancer deaths  The Financial Chronicle2 months ago
Med India

9 Month Herceptin Breast Cancer Treatment Significantly Increases Survival Rate

Julia Samuel on March 2, 2017 at 3:30 PM Health Watch Highlights The chemotherapy drug Herceptin is prescribed for patients with breast cancer after a surgery. The treatment is actually given for 12 months but can be given for 9 months, according to a study.
 Med India2 months ago

WHO to help bring cheap biosimilar cancer drugs to poor

The U. N. agency said on Thursday it would invite drugmakers in September to submit applications for prequalification of so-called biosimilar versions of two such drugs on its essential medicines list, Roche's Rituxan and Herceptin.
 DNA3 weeks ago

European shares edge down, Melrose and Subsea impress

* STOXX 600 down 0.2 pct * Utilities best sectoral performers * Disappointments from Capita, Travis Perkins weigh * Engie rises on results beat * Drug trial success boosts Roche * Adecco drops after results * Eyes on Luxottica's drop after lukewarm results ...
 Sify2 months ago

European shares steady, strong results boost Melrose and Subsea

LONDON, March 2 (Reuters) - European shares steadied earlyon Thursday, pausing after a strong rally in the previoussession, with strong earnings updates driving shares in MelroseIndustries and Subsea 7. The pan-European STOXX 600 index was flat inpercentage ...
 Sify2 months ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less